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The effect of pure human insulin-like growth factor I (IGF I) on the colony formation of late stage 
erythroid precursor cells (CFU-e) from fetal mouse liver and adult bone marrow was studied in a serum- 
free culture system. We found that IGF I in physiological concentrations stimulated erythroid colony 
formation. The combined effect of IGF I and erythropoietin was smaller than the sum of their single 
effects. The number of colonies induced by IGF I was linearly dependent on the number of plated cells. 
Our results indicate that IGF I is the first clearly defined mitogen that stimulates the late stages of erythroid 
differentiation i dependently of erythropoietin. 
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1. INTRODUCTION 
Insulin is capable of stimulating the growth of 
late erythroid precursor cells (CFU-e) [l]. This 
growth-enhancing effect of insulin did not require 
the presence of the glycoprotein hormone erythro- 
poietin (Ep) that is thought to be indispensable for 
the proliferation of CFU-e [2]. The stimulating ef- 
fect of insulin on erythroid colony formation could 
only be observed at supraphysiological concentra- 
tions of the hormone, the concentration for the 
half-maximal effect being 5 orders of magnitude 
higher than the physiological insulin concentra- 
tion. Such a mitogenic effect of high concentra- 
tions of insulin has been demonstrated for various 
other cell types in vitro [3]. In fibroblast cultures 
[4] the growth enhancing capacity of insulin is 
mediated by receptors which bind insulin with a 
low affinity but have a high affinity for the insulin- 
like growth factors (IGF I and IGF II) [5]. To test 
the hypothesis that the effect of insulin on colony 
formation of CFU-e is due to a direct effect of IGF 
we have examined the influence of IGF I on the 
growth of CFU-e in a serum-free culture system. 
We found that IGF I in the physiological concen- 
tration range greatly enhances erythroid colony 
formation in fetal mouse liver and adult-mouse 
bone marrow independently of Ep. 
2. MATERIALS AND METHODS 
2.1. Erythroid colony assay 
Effects of IGF I and Ep were studied using the 
in vitro bioassay for Ep. Liver cells were obtained 
from 13-day fetal NMRI mice (Dr Ivanovas, 
Kisslegg). Bone marrow cell suspensions were 
prepared from femurs of adult female mice. The 
test procedure was essentially that in [6] except hat 
fetal bovine serum was replaced by a serum-free 
incubation medium according to [7]. Cells were 
cultured in 4-well dishes (Greiner/FRG). Dishes 
were incubated for 48 h at 37°C in a humidified 
atmosphere containing 20% 02, 5% CO,, balance 
N,, using 02- and CO*-controlled incubators 
(Heraeus, Hanau). Cultures were evaluated as in 
[8]. Each experiment represents the mean of 3 
replicate wells. Repetition of experiments was done 
with different cell preparations. 
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2.2. Erythropoietin 
Human urinary Ep, supplied by the National 
Institutes of Health (MD), was standardized against 
the International Reference Preparation B in the 
exhypoxic polycythemic mouse assay for Ep. 
2.3. IGF I 
A stock solution (lOpg/ml) of pure human IGF 
I in Iscoves modified Dulbecco medium (Gibco) 
containing 1% deionized albumin was stored at 
-60°C until use. IGF I was kindly provided by 
Professor E.R. Froesch (Zurich). 
3. RESULTS AND DISCUSSION 
fetal mouse liver and adult bone marrow in a 
serum-free culture medium. The molar concentra- 
tions of Ep and IGF I were calculated using M, 
40000 and spec. act. 70000 U/mg for Ep [9] and 
Mr 7500 for IGF I [lo]. It can be seen that IGF I 
stimulated the growth of erythroid colonies in a 
dose-dependent manner. The percent increase of 
the number of colonies upon raising the molar con- 
centration of IGF I was similar for CFU-e from 
both adult and fetal erythroid tissue. This parallels 
the similar responsiveness of CFU-e towards Ep 
from adult and fetal erythroid tissue in a serum- 
free culture system (fig. 1, left curve). The dose- 
response curve of Ep on CFU-e colony formation 
in adult bone marrow fits very well with the curve 
in [7] obtained with the same culture system. 
The dose-response curve for IGF I was only half 
Fig. 1 shows the effect of Ep and IGF I on the 
growth of 2 day erythroid colonies (CFU-e) from 
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Fig. 1. Formation of erythroid colonies from fetal mouse liver cells and adult bone marrow cells grown for 2 days in 
vitro in the presence of Ep or IGF I. The concentrations of the hormones are given on a molar basis. The number of 
CFU-e colonies is expressed as a percentage of the maximum response to Ep (2530 + 120 colonies/lO’ cells, 
mean + SEM of 13 obs. for fetal liver cells and 203 + 60 colonies/105 cells, mean k SEM of 3 obs. for adult bone 
marrow cells) in the same experiment. 
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as steep as for Ep (fig. 1). This could be due to the are known to mediate the effects of the growth 
formation of IGF-dimers at higher concentrations hormone (GH) [15,16]. In view of these connec- 
of the mitogen, which in analogy to the dimer for- tions the effect of IGF I on colony formation from 
mation of insulin [ 111, might lead to a diminished CFU-e could explain various reports demonstrating 
biological activity. a stimulation of erythropoiesis by GH [17,18]. 
A comparison of the molar concentrations of Ep 
and IGF I which give rise to 50% of the maximum 
number of colonies, shows that the potency of Ep is 
by 4 orders of magnitude greater than that of IGF I. 
However, in doing such comparisons it should be 
noted that the plasma concentrations of Ep and 
IGF I under normal conditions are about 10-i’ M 
[12] and lo-’ M [13], respectively. Therefore, 
both substances are likely to be about equally ef- 
fective in stimulating late erythroid differentiation 
under physiological conditions. 
Furthermore, the number of erythroid colonies 
stimulated by IGF I was linearly dependent on the 
number of plated cells. This finding supports the 
idea that there is a direct effect of IGF I on CFU-e 
which is not mediated by co-cultivated cells. 
The combined effect of Ep an IGF I was smaller 
than the sum of the single effects of Ep and IGF I 
(table 1). In the presence of saturating concentra- 
tions of Ep, addition of IGF I did not lead to a fur- 
It has become increasingly apparent hat the late 
stages (CFU-e) of erythroid differentiation are en- 
hanced by growth factors other than Ep. The 
sources of these factors comprise medium from 
lectin-stimulated mouse spleen cells [ 19,201 and 
human mononuclear cells [21] as well as from un- 
stimulated human malignant cell lines [22,23]. 
Since all these growth factors have been opera- 
tionally defined as anything that enhances the for- 
mation of CFU-e colonies in culture, it is not clear 
whether the CFU-e promoting activities from 
various sources are different in nature or not. 
IGF I on the other hand, is a mitogen of which the 
chemical structure has been established in great 
detail [lo]. Therefore, IGF I is the first clearly 
defined mitogen that stimulates the late stages of 
erythroid differentiation independently of Ep. 
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ther increase in the number of colonies. This in- 
dicates that both hormones act on the same cell 
population. IGF I is strongly related to the family 
of somatomedins [ 141, a group of mitogens which 
Our sincere thanks are to Professor E.R. 
Froesch for supplying us with IGF I. This work 
was financially supported by the Sonderfor- 
schungsbereich 43 of the Deutsche Forschungs- 
gemeinschaft . 
Table 1 
Effect of Ep on the growth of erythroid colonies from 
fetal mouse livers in the presence of IGF I 
10 ng/ml 100 ng/ml 
(1.3~10-~M)(1.3~10-~ M) 
0 
(f3) 
24+3 52*2 
(5) (5) 
5 mu/ml 25+4 42+1 not 
(1.8 x lo-” M) (13) (4) determined 
10 mu/ml 42?2 not 7324 
(3.6 x 10-i* M) (13) determined (4) 
120 mu/ml 98+2 not 105*4 
(4.3 x lo-” M) (13) determined (4) 
The number of erythroid colonies is expressed as a 
percentage of the maximum response to Ep (2530+ 120 
colonies/105 cells, mean + SEM, n = 13) in the same 
experiment. Numbers in parenthesis indicate the number 
of experiments 
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